MULDERLAB

Our immune system has evolved to fight off a variety of threats, including infectious diseases and cancer. Unfortunately, these threats are not always properly tackled and diseases develop. We produce, evaluate and translate innovative nanoimmunotherapy and precision imaging approaches for the treatment and diagnosis of cardiovascular and infectious diseases, cancer and transplantation... The MulderLab consists of two teams spanning two institutions in the south of the Netherlands, namely the Radboud University Medical Center and the Eindhoven University of Technology. We are involved and maintain many formal collaborations, most notably with Mount Sinai's Biomedical Engineering and Imaging Institute and its Nanomedicine Lab, which Willem Mulder founded in 2006 and directed until December 2020... The MulderLab develops innovative immunotherapy strategies based on nanomedicine, a process that is guided by imaging. We focus primarily on targeting innate immunity with nanomaterials that..

Primary location: Nijmegen Netherlands